MiR-30a level is decreased during Th17 differentiation and process of MS and EAE.
Enforced constitutive expression of miR-30a inhibits Th17 differentiation.
In vivo miR-30a overexpression leads to fewer Th17 generation and alleviative EAE.
IL-21R is a direct target of miR-30a.